BioPharmaceutics Dr Farah Flashcards

1
Q

Pharmacokinetics is _________________

A

the study of the kinetics of absorption, distribution, metabolism and excretion (ADME) of the drugs and their corresponding pharmacologic, therapeutic or toxic
response in animals and man.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Absorption: is ____________________

Distribution: the __________________

The distribution of the drug between tissues is dependent on ____________________

A

the movement of the drug into the blood stream.

reversible transfer of a drug from one location to another within the body.

vascular permeability, regional blood flow, cardiac output and perfusion rate of the tissue and the ability of the drug to
bind tissue and plasma proteins and its lipid solubility.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pH partition plays a major role as well.

 The drug is easily distributed in ________________
 It is distributed in small quantities through_______________
 Metabolism: is the metabolic _________________________

A

highly perfused organs such as the liver, heart and kidney.

less perfused tissues like muscle, fat and peripheral organs.

breakdown of drugs by living organisms, usually through specialized enzymatic systems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pH partition plays a major role as well.

 The rate of metabolism determines ________________
 Excretion/ elimination: of a drug is one of ___________
 The kidney is the main ________________. These organs or structures use specific routes to expel a drug from the body, these are termed elimination pathways.

A

the duration and intensity of a drug’s pharmacologic action.

a number of processes by which a drug is eliminated from an organism either in an unaltered form (unbound molecules) or modified as a metabolite.

excretory organ although others exist such as the liver, the skin, the lungs or glandular structures, such as
the salivary glands and the lacrimal glands.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

the higher the surface area the higher the _____________

A

dissolution rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe slide 4

A

see slide 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what makes up the Total body fluid(40L)

ECF (extracellular fluid) 15L

Interstitial fluid (12L)

Blood plasma
(3L)

ICF(intracellular fluid) 25L
Blood
plasma
(3L)

Transcellular
fluid(5L)

A

ECF (extracellular fluid) 15L

ICF(intracellular fluid) 25L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Blood plasma is __

A

3 litres

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Transcellular fluid is ____________

A

5 litres

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is biopharmaceutics

A

It is the study of physiochemical properties of the drugs, their proper dosage form in which administered and the route of administration as related to the onset, duration and intensity of drug action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Biopharmaceutics embraces the knowledge of factors that influence: list 4

A
  1. Protection of the pharmacological activity of the drug in the drug product
  2. The release of the drug from drug product
  3. The rate of dissolution of drug at the site of administration
  4. The system absorption of the drug (rate and extent).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical pharmacokinetics

“Study of time course of _____________________”

This science may be applied to a wide range of clinical situations (renal, cardiac, hepatic, diabetes mellitus etc)

More correctly clinical pharmacokinetics is the ______________________________

A

absorption, distribution, metabolism and excretion of drugs and their corresponding pharmacological response.

application of pharmacokinetic principles in appropriate and rational drug therapy patient’s status (host factors)and disease state influence the PK of the drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which study deals with the Pk differences of drugs in various population groups.

A

Population pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Toxicokinetic evaluation is both a ____and ________requirement in the drug development process.

A

regulatory

scientific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Toxicokinetic

It includes the generation of data to asses the systemic exposure. These data (ADME)help to understand _______ to and also play a role in clinical setting, assisting in the setting of plasma limits for ____________

A

observed toxicity

administered dose

early human exposure and in calculation of safety margins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug substance is

A

It is the active pharmaceutical ingredient or component in the drug product that produces the pharmacodynamic activity

17
Q

Drug product is

A

A drug product is the finished dosage form (tablets, syrups or injections) that contains the active ingredient

18
Q

Bioequivalence requirement is?

A

The requirement imposed by FDA for in vitro and in vivo testing of particular drug products which must be satisfied as a condition of marketing.

19
Q

Bioequivalent drug products

For systemically absorbed drugs the test drug (generic/non patent)and reference drug (branded)shall be considered bioequivalent

  1. If the rate and extent of absorption of test drug don’t differ significantly from the ~_____________when given administered at the same molar dose of therapeutic ingredient under ________________
A

rate and extent of absorption of reference drug

similar experimental conditions in either a single dose or multiple doses.

20
Q

Bioequivalence

The extent of absorption of test drug does not show significant difference from _____________when at the same molar dose of therapeutic ingredient under ______________. As well, this difference in rate of absorption does not influence therapeutic objectives when test drug used chronically.

A

the extent of absorption of reference drug

similar experimental conditions in either a single dose or multiple doses and the difference from the reference drug in rate of absorption of test is intentional and mentioned on its proposed labelling

21
Q

Drug concentration

Drug concentration is __________________

Drug levels are measured in ________________

A

an important element in determining individual or population pharmacokinetics

biological samples like plasma, saliva, milk and urine. Sometimes hair and nails are also sites where drugs can accumulate.

22
Q

Two methods are used for sampling

  1. Non- invasive method:

Include sampling of urine, saliva, milk, faeces, expired air or any other biological material that can be obtained without parenteral or surgical intervention.

A

Invasive method

Non- invasive method

23
Q

Invasive method includes?

A

Include sampling of blood, spinal fluid, synovial fluid, tissue biopsy or any biological material that requires parenteral or surgical intervention in the patient.

24
Q

Non- invasive method includes

A

Include sampling of urine, saliva, milk, faeces, expired air or any other biological material that can be obtained without parenteral or surgical intervention.

25
Q

______________ is the most convenient and direct method to assess the PK of the drug in the body.

Whole blood contains_______________.

_______________ is most commonly used for measuring drug concentration.

Plasma perfuses _______________

For practical purpose, it is assumed that t____________is in dynamic equilibrium with the tissues, the changes in plasma drug concentration will reflect corresponding changes in tissue drug concentration.

Plasma: __________coloured clear liquid, _________% water,____________% of solid Serum= plasma -fibrinogen

A

Measurement of drug concentration in the blood, plasma or serum is the most convenient and direct method to assess the PK of the drug in the body.

Whole blood contains formed elements (WBCs, RBCs and platelets) and protein like albumin and globulins.

Generally serum or plasma is most commonly used for measuring drug concentration.

Plasma perfuses all tissues of the body and cellular elements in the blood.

For practical purpose, it is assumed that the drug in plasma is in dynamic equilibrium with the tissues, the changes in plasma drug concentration will reflect corresponding changes in tissue drug concentration.

Plasma: straw coloured clear liquid 91 to 92% water, 8 to 9% of solid Serum= plasma -fibrinogen

26
Q

Plasma Level time curve

The plasma level time curve is _______________

Samples are taken at _______________

The concentration in each plasma sample is plotted on ___________________.

A

The plasma level time curve is constructed by measuring drug concentrations in plasma

Samples are taken at various time intervals after the administration of a drug product.

The concentration in each plasma sample is plotted on rectilinear graph paper against corresponding time at which the sample was withdrawn.

27
Q

Minimum effective concentration (MEC) represents ______________(for therapeutic purpose this the minimum concentration needed to be present at the receptor to produce desired effect)

A

MEC represents the minimum concentration of the drug needed to produce the pharmacological effect (for therapeutic purpose this the minimum concentration needed to be present at the receptor to produce desired effect)

28
Q

Minimum toxic concentration(MTC) reflects _________________

A

Minimum toxic concentration(MTC) reflects the minimum concentration of drug needed to need just barely produce a toxic effect

29
Q

Intensity of pharmacological response is proportional ___________, which is reflected in the observation that higher plasma drug concentrations produce___________

A

Intensity of pharmacological response is proportional to the number of drug receptors occupied, which is reflected in the observation that higher plasma drug concentrations produce a greater response, up to a maximum.

30
Q

___________corresponds to the time required for the drug concentration to reach the MEC.

A

Onset time.

31
Q

The time between the administration of the drug and the start of the absorption is _________

A

Lag time

32
Q

Time required to reach Cmax is

A

Tmax.

33
Q

what represents the maximum plasma drug concentration obtained after administration of drug. (usually by oral route)

A

Peak plasma level (Cmax).

34
Q

Drug concentration in urine and faeces

The measurement of drug concentration in urine is ___________________

The rate and extent of drug excretion reflects ________________

Urinary blood excretion data can also be used to calculate _______________

_____________ reflects the amount of unabsorbed drug following oral administration of a dose or may reflect the amount of drug that is secreted in bile ( and not reabsorbed) after systemic absorption.

A

The measurement of drug concentration in urine is indirect method of measuring the bioavailability.

The rate and extent of drug excretion reflects the rate and extent of systemic drug absorption.

Urinary blood excretion data can also be used to calculate PK parameters.

Measurements of drug in faeces reflects the amount of unabsorbed drug following oral administration of a dose or may reflect the amount of drug that is secreted in bile ( and not reabsorbed) after systemic absorption.

35
Q

Drug concentration in saliva

__________diffuses in saliva

Saliva drug levels nearly parallel the free drug rather than ________________

The saliva drug concentrations, taken after equilibrium with plasma drug concentration, generally provides____________________

A

Free drug (unbound) diffuses in saliva

Saliva drug levels nearly parallel the free drug rather than total plasma drug concentration.

The saliva drug concentrations, taken after equilibrium with plasma drug concentration, generally provides more stable indication of drug levels in the body.

36
Q

_______________is the measure of rate and extent of active ingredients or active moiety of a drug product that reaches the systemic circulation and becomes available at the site of action.

______________is the availability of the drug from a drug product (test) compared to a recognized standard (reference).

                               R.A= [AUC]test/[AUC]reference
A

Bioavailability is the measure of rate and extent of active ingredients or active moiety of a drug product that reaches the systemic circulation and becomes available at the site of action.

Relative availability:

is the availability of the drug from a drug product (test) compared to a recognized standard (reference).

                               R.A= [AUC]test/[AUC]reference
37
Q

stop

A

stopped at slide 24